In CRC-LM samples, TGFBI could be detected frequently also in cancer cells (pan-cytokeratin-positive) (Figure 1C), although its expression remained predominant in stromal cells (vimentin-positive). This evidence concerns the gene TGFBI and colorectal carcinoma.